V

Varian

Tech-enabled radiation oncology hardware and software

Pharmaceutical Lab Technician

Full-TimeUpdated on 10/4/2026
$48.8k - $67k+ 5% bonus + 100% 401(k) match
Entry
Atlanta, GA, USA
In PersonPrimarily overnight work; must be willing to rotate into alternative shifts as business needs evolve.
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A high school diploma or equivalent is required; specialized skill training or certification may be required.
  • Applicants must be comfortable working in a fast-paced laboratory environment and able to lift up to 100 pounds.
  • Willingness to work overtime as needed.
  • Basic computer skills, including spreadsheets, word processing, and email.
  • Ability to work independently.
  • Effective verbal and written communication skills.
  • Ability to apply standard operating procedures in a production environment.
  • Ability to maintain a sterile environment.
  • Ability to understand, prioritize, and implement laboratory safety protocols.
Responsibilities
  • Operate chemistry instruments, including high-performance liquid chromatography, gas chromatography, thin-layer chromatography, and chemistry modules, as well as cyclotron systems, for routine manufacturing and quality control of radiopharmaceuticals.
  • Author and maintain precise documentation for manufacturing, quality control, preventive maintenance, customer support, laboratory investigations, deviations, and out-of-specification events.
  • Perform preventive maintenance, inspections, and troubleshooting of critical equipment.
  • Prepare products for shipment, coordinate courier logistics, and provide customer support.
  • Maintain aseptic cleanroom environments to create sterile consumables and prevent contamination during production of injectable materials.
  • Conduct environmental monitoring on a regular and defined basis.
  • Maintain compliance with safety, sterile-environment, and regulatory standards.
  • Assist with facility housekeeping, maintain laboratory inventory levels, and create quality control documentation as needed.
  • Communicate regularly with couriers and customers to ensure accurate and timely delivery of biomarkers.
Desired Qualifications
  • Previous experience in a pharmacy environment or equivalent.
  • Understanding of current Good Manufacturing Practices and Good Documentation Practices.
  • Previous work experience in a laboratory environment or related role.
  • Previous experience with analytical laboratory equipment and laboratory software systems.
  • Familiarity with radiation safety or ALARA principles.
  • Strong command of Good Documentation Practices to ensure data integrity and audit readiness.
  • Strong problem-solving, analytical, critical-thinking, organizational, and interpersonal skills; attention to detail.
  • Ability to treat confidential information with sensitivity.
  • Ability to meet deadlines and work in a fast-paced, multi-priority environment.
  • Ability to plan and organize job responsibilities and priorities.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Health Insurance

Dental Insurance

Vision Insurance

Wellness Program

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

↑ 3%

1 year growth

↑ 3%

2 year growth

↑ 3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.